CA-111

N/A

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameCA-111
Drug Alias NameCA111CA-111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsGlucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsBody Weight
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChongqing Chenan Biopharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChongqing Chenan Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBody Weight
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A